Pregnancy and infant outcomes by trimester of SARS‐CoV ‐2 infection in pregnancy– SET‐NET , 22 jurisdictions, January 25, 2020–December 31, 2020
Birth Defects Research · 15.01.2023 · 115 (2) · 145-159
DOI: 10.1002/bdr2.2081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Birth Defects Research, online erschienen am 06.09.2022. Verfasst von Varsha Neelam und 30 weiteren Autor:innen. Beteiligte Einrichtung: Centers for Disease Control and Prevention COVID-19 Response, Epidemiology Task Force, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: COVID-19, Premature Birth, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases Cooperative Agreement.
Abstract (Originalsprache)
Objectives We describe clinical characteristics, pregnancy, and infant outcomes in pregnant people with laboratory‐confirmed SARS‐CoV‐2 infection by trimester of infection. Study Design We analyzed data from the Surveillance for Emerging Threats to Mothers and Babies Network and included people with infection in 2020, with known timing of infection and pregnancy outcome. Outcomes are described by trimester of infection. Pregnancy outcomes included live birth and pregnancy loss (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centers for Disease Control and Prevention COVID-19 Response, Epidemiology Task Force, Atlanta, Georgia, USA.
- Eagle Global Scientific, LLC, Atlanta, Georgia, USA.
- New Jersey Department of Health, Trenton, New Jersey, USA.
- Tennessee Department of Health, Nashville, Tennessee, USA.
- Massachusetts Department of Public Health, Boston, Massachusetts, USA.
- University of Iowa College of Public Health, Iowa City, Iowa, USA.
ORCID-Profile: Kate R Woodworth, Paul Romitti, Sascha Ellington, Van T Tong, Suzanne M Gilboa
Förderung
- Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases Cooperative Agreement
Zitieren
APA
Neelam, V., Reeves, E. L., Woodworth, K. R., O'Malley Olsen, E., Reynolds, M. R., Rende, J., Wingate, H., Manning, S. E., Romitti, P., Ojo, K. D., Silcox, K., Barton, J., Mobley, E., Longcore, N. D., Sokale, A., Lush, M., Delgado-Lopez, C., Diedhiou, A., Mbotha, D., …, & Gilboa, S. M. (2023). Pregnancy and infant outcomes by trimester of SARS‐CoV ‐2 infection in pregnancy– SET‐NET , 22 jurisdictions, January 25, 2020–December 31, 2020. Birth Defects Research, 115(2), 145-159. https://doi.org/10.1002/bdr2.2081
Vancouver
Neelam V, Reeves EL, Woodworth KR, O'Malley Olsen E, Reynolds MR, Rende J, et al. Pregnancy and infant outcomes by trimester of SARS‐CoV ‐2 infection in pregnancy– SET‐NET , 22 jurisdictions, January 25, 2020–December 31, 2020. Birth Defects Research. 2023;115(2):145-159. doi:10.1002/bdr2.2081
BibTeX
@article{Neelam2023,
author = {Neelam, Varsha and Reeves, Emily L and Woodworth, Kate R and O'Malley Olsen, Emily and Reynolds, Megan R and Rende, Joy and Wingate, Heather and Manning, Susan E and Romitti, Paul and Ojo, Kristen D and Silcox, Kristin and Barton, Jerusha and Mobley, Evan and Longcore, Nicole D and Sokale, Ayomide and Lush, Mamie and Delgado-Lopez, Camille and Diedhiou, Abdoulaye and Mbotha, Deborah and Simon, Wanda and Reynolds, Bethany and Hamdan, Tahani S and Beauregard, Suzann and Ellis, Esther M and Seo, Jennifer Y and Bennett, Amanda and Ellington, Sascha and Hall, Aron J and Azziz-Baumgartner, Eduardo and Tong, Van T and Gilboa, Suzanne M},
title = {Pregnancy and infant outcomes by trimester of SARS‐CoV ‐2 infection in pregnancy– SET‐NET , 22 jurisdictions, January 25, 2020–December 31, 2020},
journal = {Birth Defects Research},
year = {2023},
volume = {115},
number = {2},
pages = {145--159},
doi = {10.1002/bdr2.2081}
}
EUVIMED